Emerging Resistance to Empiric Antimicrobial Regimens for Pediatric Bloodstream Infections in Malawi (1998–2017)
Open accessThe DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
BACKGROUND: The adequacy of the World Health Organization's Integrated Management of Childhood Illness (IMCI) antimicrobial guidelines for the treatment of suspected severe bacterial infections is dependent on a low prevalence of antimicrobial resistance (AMR). We describe trends in etiologies and susceptibility patterns of bloodstream infections (BSI) in hospitalized children in Malawi. METHODS: We determined the change in the population-based incidence of BSI in children admitted to Queen Elizabeth Central Hospital, Blantyre, Malawi (1998-2017). AMR profiles were assessed by the disc diffusion method, and trends over time were evaluated. RESULTS: A total 89643 pediatric blood cultures were performed, and 10621 pathogens were included in the analysis. Estimated minimum incidence rates of BSI for those ≤5 years of age fell from a peak of 11.4 per 1000 persons in 2002 to 3.4 per 1000 persons in 2017. Over 2 decades, the resistance of Gram-negative pathogens to all empiric, first-line antimicrobials (ampicillin/penicillin, gentamicin, ceftriaxone) among children ≤5 years increased from 3.4% to 30.2% (P < .001). Among those ≤60 days, AMR to all first-line antimicrobials increased from 7.0% to 67.7% (P < .001). Among children ≤5 years, Klebsiella spp. resistance to all first-line antimicrobial regimens increased from 5.9% to 93.7% (P < .001). CONCLUSIONS: The incidence of BSI among hospitalized children has decreased substantially over the last 20 years, although gains have been offset by increases in Gram-negative pathogens' resistance to all empiric first-line antimicrobials. There is an urgent need to address the broader challenge of adapting IMCI guidelines to the local setting in the face of rapidly-expanding AMR in childhood BSI.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Point-of-care tests for diagnosing infections in the developing world
Peeling, R. W., & Mabey, D. (2010) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2010.03279.x · Cited by 500 · cited 1×
“68 • CID 2019:69 (1 July) • Iroh Tam et al initiatives to expand access to high-quality laboratory surveillance [33, 34] and the development of rapid diagnostics [35, 36], there should be a considerable emphasis on expanded access to effective antimicrobials in the context of locally-relevant antimicrobial stewardship…”
BackgroundMusicha, P., Cornick, J. E., Bar-Zeev, N., French, N., Masesa, C., Denis, B., Kennedy, N., Mallewa, J., Gordon, M. A., Msefula, C. L., et al. (2017) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(17)30394-8 · Cited by 300 · cited 2×
“A growing problem has been increasing rates of antimicrobial resistance (AMR) [12, 13], which may be caused and compounded by inappropriate prescribing, under-dosing, and nonadherence to guidelines [14, 15].”
BackgroundSelf-citationFeasey, N. A., Hadfield, J., Keddy, K. H., Dallman, T. J., Jacobs, J., Deng, X., Wigley, P., Barquist, L., Langridge, G. C., Feltwell, T., et al. (2016) · Nature Genetics · doi:10.1038/ng.3644 · Cited by 217 · cited 1×
“We have previously reported three epidemics of Salmonella which appear to have arisen through the acquisition of virulence and antimicrobial resistance determinants in the context of a susceptible population [19-22].”
BackgroundSelf-citationRapid Emergence of Multidrug Resistant, H58-Lineage Salmonella Typhi in Blantyre, Malawi
Feasey, N. A., Gaskell, K., Wong, V., Msefula, C., Selemani, G., Kumwenda, S., Allain, T. J., Mallewa, J., Kennedy, N., Bennett, A., et al. (2015) · PLOS Neglected Tropical Diseases · doi:10.1371/journal.pntd.0003748 · Cited by 167 · cited 1×
“We have previously reported three epidemics of Salmonella which appear to have arisen through the acquisition of virulence and antimicrobial resistance determinants in the context of a susceptible population [19-22].”
BackgroundSelf-citationDaza, P., Banda, R., Misoya, K., Katsulukuta, A., Gessner, B. D., Katsande, R., Mhlanga, B. R., Mueller, J. E., Nelson, C. B., Phiri, A., et al. (2006) · Vaccine · doi:10.1016/j.vaccine.2006.05.076 · Cited by 71 · cited 1×
“pneumoniae conjugate vaccine in 2011), rapid roll-out of HIV prevention and care and improvements in malaria control [6-11].”
Background
Cited by
Weiss, S. L., Peters, M. J., Alhazzani, W., Agus, M. S. D., Flori, H. R., Inwald, D. P., Nadel, S., Schlapbach, L. J., Tasker, R. C., Argent, A. C., et al. (2020) · Pediatric Critical Care Medicine · doi:10.1097/pcc.0000000000002198 · Cited by 1,228
Weiss, S. L., Peters, M. J., Alhazzani, W., Agus, M. S. D., Flori, H. R., Inwald, D. P., Nadel, S., Schlapbach, L. J., Tasker, R. C., Argent, A. C., et al. (2020) · Intensive Care Medicine · doi:10.1007/s00134-019-05878-6 · Cited by 606
The scope of the antimicrobial resistance challenge
Okeke, I. N., de Kraker, M. E. A., Van Boeckel, T. P., Kumar, C. K., Schmitt, H., Gales, A. C., Bertagnolio, S., Sharland, M., & Laxminarayan, R. (2024) · The Lancet · doi:10.1016/s0140-6736(24)00876-6 · Cited by 474
Donkor, E. S., Muhsen, K., Johnson, S. A. M., Kotey, F. C. N., Dayie, N. T. K. D., Tetteh-Quarcoo, P. B., Tette, E. M. A., Osei, M.-M., Egyir, B., Nii-Trebi, N. I., et al. (2023) · Antibiotics · doi:10.3390/antibiotics12020255 · Cited by 46
Kasumba, I. N., Pulford, C. V., Perez-Sepulveda, B. M., Sen, S., Sayed, N., Permala-Booth, J., Livio, S., Heavens, D., Low, R., Hall, N., et al. (2021) · Clinical Infectious Diseases · doi:10.1093/cid/ciab051 · Cited by 25
“Although the incidence of iNTS has declined in many sites across Africa [10], it is still one of the most common causes of bloodstream infections in African children [11].”
Background
Metadata
- Authors
- Iroh Tam, P.-Y., Musicha, P., Kawaza, K., Cornick, J., Denis, B., Freyne, B., Everett, D., Dube, Q., French, N., Feasey, N., & Heyderman, R.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2018-10-01
- Volume
- 69
- Issue
- 1
- Pages
- 61-68
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2894643501
- Cited by
- 89
- References
- 5
- FWCI
- 4.85
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.